Vasoplegic syndrome is a well-recognized complication during cardiopulmonary bypass (CPB) and is associated with increased morbidity and mortality. especially when refractory to conventional vasoconstrictor therapy. This is the first reported case of vasoplegia on CPB unresponsive to methylene blue whereas responsive to hydroxocobalamin. which indicates that the effect of hydroxocobal... https://www.animationbengal.com/?w=quick-buy-yale-bulldogs-law-school-discount-great-price